Search
Search Results
##search.searchResults.foundPlural##
-
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1669PDF: 539HTML: 206 -
MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.
1212PDF: 594HTML: 216 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
9969PDF: 984HTML: 210 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
1806PDF: 852HTML: 3594Diamond Blackfan Anemia: A Tertiary care centre experience: 255 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
749PDF: 540HTML: 160 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1037PDF: 926Suppl. Files: 594HTML: 83 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4245PDF: 1517HTML: 447 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1362PDF: 528HTML: 197 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1311PDF: 863HTML: 1032Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 175 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1614PDF: 990HTML: 358 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1576PDF: 604HTML: 190 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1242PDF: 728HTML: 373 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4812PDF: 1800HTML: 2134 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2631PDF: 943HTML: 3605 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2307PDF: 954HTML: 11129 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1765PDF: 993HTML: 1782Tables: 179 -
Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples
1144PDF: 480HTML: 1162Amato1: 166Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 240jdoe, : 248Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 152 -
-
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1865PDF: 689HTML: 236 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1062PDF: 1240Suppl. Files: 146HTML: 69 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6955PDF: 3920HTML: 24881 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1075PDF: 837HTML: 96 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12345PDF: 1681HTML: 4171Cover letter: 197Figure 1: 204







